Remy Luthringer
CEO · Minerva Neurosciences, Inc.
Individual
- 2024
- Jun 5, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Remy Luthringer's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Matthew Gline - $46.17M in ROIV purchases and sales in the last 12 months
- Larry Robbins - $46.04M in BFLY purchases and sales in the last 12 months
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Remy Luthringer?
Remy Luthringer is a corporate insider, tracked as CEO of Minerva Neurosciences, Inc. (NERV). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Remy Luthringer last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 2 filings going back to 2024.